During the past decade, Klinik und Poliklinik für Onkologie und Hämatologie Universitätsmedizin Charité Mitte conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinik und Poliklinik für Onkologie und Hämatologie Universitätsmedizin Charité Mitte" #1 collaborator was "Parexel" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Klinik und Poliklinik für Onkologie und Hämatologie Universitätsmedizin Charité Mitte" are "Chemotherapy-Induced Nausea and Vomiting" (2 trials). Many other conditions were trialed in "Klinik und Poliklinik für Onkologie und Hämatologie Universitätsmedizin Charité Mitte" in a lesser frequency.

Most popular intervention types in "Klinik und Poliklinik für Onkologie und Hämatologie Universitätsmedizin Charité Mitte" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (2 trials), "I.V. palonosetron" (1 trials), "Netupitant and Palonosetron" (1 trials), "Oral palonosetron" (1 trials) and "Palonosetron" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinik und Poliklinik für Onkologie und Hämatologie Universitätsmedizin Charité Mitte" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Klinik und Poliklinik für Onkologie und Hämatologie Universitätsmedizin Charité Mitte". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Klinik und Poliklinik für Onkologie und Hämatologie Universitätsmedizin Charité Mitte, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinik und Poliklinik für Onkologie und Hämatologie Universitätsmedizin Charité Mitte, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".